IL2 and B-cell non-Hodgkin lymphoma: Vδ2 T cells from patients with B-cell lymphoma and MM, expanded in vitro by culture with zoledronate and IL-2, displayed enhanced cytotoxic effects towards MM/B-cell lymphoma cell lines and autologous tumor cells, without cytotoxicity against normal cells in these patients (31).